Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
2. Knoppers BM. Biobanking: international norms. J Law Med
Ethics 2005; 33:7–14.
3. Watson PH, Barnes RO. A proposed schema for classifying hu-
man research biobanks. Biopreserv Biobank 2011; 9:327–333.
4. Elseman E, Haga SB. Handbook of human tissue sources. Santa
Monica: Rand; 1999.
5. Danish National Biobank [Internet]. http://www.ssi.dk/English.
Accessed June 18, 2012.
6. UK Biobank [Internet]. http://www.ucl.ak/biobank. [Accessed
17 July 2012].
7. Ollier W, Sprosen T, Peakman T. UK biobank: from concept to
reality. Pharmacogenomics 2005; 6:639–646.
8. Greenspan JS, Conant MA, Ziegler JL, Volberding PA, De Souza
YG. The UCSF AIDSspecimen bank. LabMed 1999; 22:790–792.
9. caHUB [Internet.]. http://caHUB.cancer.gov. [Accessed 15 June
10. Vaught J, Rogers J, Myers K, Lim MD, Lockhart N, Moore H,
et al. AN NCI perspective on creating sustainable biospecimen
resources. J Natl Cancer Inst Monogr 2011; 42:1–7.
11. caHUB [Internet.]. http://biospecimens.cancer.gov/resources/
SOPs. [Accessed 21 August 2012].
12. Mayol-Heath DN, Keck AS, Woo P. Biorepository development
research: a detailed topic follow-up to the blueprint for the
development of a community-based hospital biorepository.
Biopreserv Biobank 2011; 9:253–257.
13. Winn DM, Reichman ME, Gunter E. Epidemiologic issues in the
design and use of biologic specimen banks. Epidemiol Rev
14. Brand AM, Probst-Hensch NM. Biobanking for epidemiological
research and public health. Pathobiology 2007; 74:227–238.
15. Lee LW, Grifﬁth J, Zenick H, Hulka BS. Human tissue monitor-
ing and specimen banking: opportunities for exposure assess-
ment, risk assessment, and epidemiological research. Environ
Health Perspect 1995; 103 (Suppl 3):3–8.
16. ISBER (International Society for Biological and Environmental
Repositories). 2012 Best Practices for repositories: collection,
storage, retrieval, and distribution of biological materials for
research. Biopreserv Biobank 2012; 10:79–161.
17. Riegman PHJ, Dinjens WNM, Oosterhuis JW. Biobanking for
interdisciplinary clinical research.
Pathobiology 2007; 74:239–
18. National Cancer Institute, 2011 Best practices for biospecimen
resources. [Internet]. http://biospecimens.cancer.gov/practices/
2011bp.asp. [Accessed 1 November 2011].
19. Lassalle S, Hofman V, IIie M, Butori C, Bonnetaud C, Gaziello
MC, et al. Setting up a prospective thyroid biobank for transla-
tional research: practical approach of a single institution
(2004–2009, Pasteur Hospital, Nice, France). Biopreserv Bio-
bank 2011; 9:9–19.
20. Voegele C, Alteyrac L, Caboux E, Smans M, Lesueur F, Calvez-
Kelm F, et al. A sample storage management system for bio-
banks. Bioinformatics 2010; 26:2798–2800.
21. Mills FJ, Swanberg G. A strategic approach to comprehensive
sample management. Biopreserv Biobank 2012; 10:178–180.
22. Grigorenko EL, Bouregy S. Biobanking on a small scale: practical
considerations of establishing a single-researcher biobank. Stan-
ford J Law Sci Policy 2009. See http://www.sjlsp.org/?q=node/60.
[Accessed 20 November 2012].
23. Bjun R, Casati B. Stakeholder analysis: a useful tool for biobank
planning. Biopreserv Biobank 2012; 10:239–244.
24. Betsou F, Lehmann S, Ashton G, Barnes M, Benson EE, Coppola
D, et al. Standard preanalytical coding for biospecimens:
deﬁning the sample PREanalytical code. Cancer Epidemiol
Biomarkers Rev 2010; 19:1004–1011.
25. Lehmann S, Guadagni F, Moore H, Ashton G, Barnes M, Benson
E, et al. Standard preanalytical coding for biospecimens: review
and implementation of the sample PREanalytical code (SPREC).
Biopreserv Biobank 2012; 4:366–374.
26. Kroth PJ, Schaffner V, Lipscomb M. Technological and admin-
istrative factors implementing a virtual human biospecimen
repository. AMIA Annu Symp Proc 2005; 2005:1011.
27. Elliot P, Peakman TC. The UK biobank sample handling and
storage protocol for the collection, processing and archiving of
human blood and urine. Intl J Epidemiol 2008; 37:234–244.
28. ISBER (International Society for Biological and Environmental
Repositories). ISBER best practices for repositories I: collection,
storage, and retrieval of human biological materials for
Cell Preserv Technol 2005; 3:5–48.
29. ISBER (International Society for Biological and Environmental
Repositories). 2008 Best practices for repositories. Collection,
storage, retrieval and distribution of biological materials for
research. Cell Preserv Technol 2008; 6:5–58.
30. Moore HM, Kelly A, Jewell SD, McShane LM, Clark DP,
Greenspan R, et al. Biospecimen reporting for improved study
quality. Biopreserv Biobank 2011; 9:57–70.
31. National Cancer Institute, Ofﬁce of the Deputy Director for
Advanced Technologies and Strategic Partnerships. First-genera-
tion guidelines for NCI-supported biorepositories 2005; 1–42.
32. NCI best practices for biospecimen resources. 2007 [Internet].
http://biospecimens.cancer.gov/bestpractices/. [Accessed 12
33. Eiseman E, Bloom Gabrielle Bloom, Brower J, Clancy N,
Olmsted SS. Human Tissue Repositories. ‘Best Practices’ for a
biospecimen resource for the genomic and proteomic era. Santa
Monica, CA: Rand Corporation; 2003.
34. UCSF guide for the research use of human biological specimens:
collecting, banking, and sharing specimens. 2005 [Internet].
GuideMay05.pdf. [Accessed 3 August 2012].
35. Betsou F, Barnes R, Burke T, Coppola D, De Souza Y, Eliason J,
et al. Human biospecimen research: experimental protocol and
quality control tools. Cancer Epidemiol Biomarkers Prev 2009;
36. Narayanan S. The preanalytical phase. An important compo-
nent of laboratory medicine. Am J Clin Pathol 2000; 113:429–
37. Lippi G, Salvagno GL, Montagnana M, Franchini M, Guidi GC.
Phlebotomy issues and quality improvement in results of
laboratory testing. Clin Lab 2006; 52:217–230.
38. McKenna KC, Beatty KM, Miguel RV, Bilonick RA. Delayed
processing of blood increases the frequency of activated
CD11bR CD15R granulocytes which inhibit T cell function.
J Immunol Methods 2009; 341:68–75.
39. Giselefoss RE, Grimsrud TK, Mørkrid L. Stability of selected
serum proteins after long-term storage in the Janus serum bank.
Clin Chem Lab Med 2009; 47:596–603.
40. Grizzle WE, Knoppers BM, Zeps N, Hewitt SM, Sullivan K.
What are the most oppressing legal and ethical issues facing
biorepositories and what are some strategies to address them?
Biopreserv Biobank 2011; 9:317–319.
41. Wolf SM, Crock BN, Van Ness B, Lawrenz F, Kahn JP, Beskow
LM, et al. Managing incidental ﬁndings and research results in
genomic research involving biobanks and archived data sets.
Genet Med 2012; 14:361–384.
42. Wolf SM, Lawrenz FP, Nelson CA, Kahn JP, Cho MK, Clayton
EW, et al. Managing incidental ﬁndings in human subjects
research: analysis and recommendations. J Law Med Ethics
43. Wallace SE, Kent A. Population biobanks and returning indi-
vidual research results: mission impossible or new directions?
Hum Genet 2011; 130:393–401.
44. SB 1267. 2012 [Internet] http://kern.networkofcare.org/mh/legis
[Accessed 31 July 2012].
45. CAP accreditation for biorepositories. 2011 [Internet] http://
www.cap.org. [Accessed 3 August 2012].
46. ISO 9001. 2008 [Internet]. http://www.iso.org/iso/home.htm.
[Accessed 28 July 2012].
47. Davis E, Hampson K, Bray C, Dixon K, Ollier W, Yuille M.
Selection and implementation of the ISO9001 standard to
support biobanking research infrastructure development. Bio-
preserv Biobank 2012; 10:162–167.
48. UCLA Department of Pathology & Laboratory Medicine. 2012
[Accessed 20 August 2012].
49. Pitt KE. Development of a global certiﬁcation program for
biorepository technical professionals. Biopreserv Biobank
50. ISBER self-assessment tool for biorepositories. 2012 [Internet]
http://www.isber.org/sat/. [Accessed 3 August 2012].
51. ISBER Biospecimen Working Group. Biorepository proﬁciency
testing for the quality control of biospecimens for the global
biobanking community. Biopreserv Biobank 2011; 9:415–417.
52. Shea K, Betsou F. Development of external quality assurance
programs for biorepositories. Biopreserv Biobank 2012; 4:403–
312 AIDS 2013, Vol 27 No 3